Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
celgene
4
×
clinical trials
detroit blog main
detroit top stories
drugs
4
×
indiana blog main
indiana top stories
life sciences
national
4
×
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
fda
johnson & johnson
multiple myeloma
abbvie
astrazeneca
bcma
cancer
eli lilly
gene therapy
genentech
What
bio
known
medical
roundup
american
annual
approved
ash
biopharma
biotechs
blood
borne
cancers
chose
close
companies
company
conference
congress
congressional
crispr
device
diego
digital
disease
drug
epidemic
executives
fatty
fda
feud
firms
frenzied
gathering
group
growing
guide
hematology
host
ipo
Language
Current search:
drugs
×
national
×
celgene
×
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way